Literature DB >> 20058008

Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Shiro Miyayama1, Masashi Yamashiro, Miho Okuda, Yuichi Yoshie, Yoshiko Nakashima, Hiroshi Ikeno, Nobuaki Orito, Kazuo Notsumata, Hiroyuki Watanabe, Daisyu Toya, Nobuyoshi Tanaka, Osamu Matsui.   

Abstract

The purpose of this study was to evaluate the clinical course of main bile duct stricture at the hepatic hilum after transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Among 446 consecutive patients with HCC treated by TACE, main bile duct stricture developed in 18 (4.0%). All imaging and laboratory data, treatment course, and outcomes were retrospectively analyzed. All patients had 1 to 2 tumors measuring 10 to 100 mm in diameter (mean ± SD 24.5 ± 5.4 mm) near the hepatic hilum fed by the caudate arterial branch (A1) and/or medial segmental artery (A4) of the liver. During the TACE procedure that caused bile duct injury, A1 was embolized in 8, A4 was embolized in 5, and both were embolized in 5 patients. Nine patients (50.0%) had a history of TACE in either A1 or A4. Iodized oil accumulation in the bile duct wall was seen in all patients on computed tomography obtained 1 week later. Bile duct dilatation caused by main bile duct stricture developed in both lobes (n = 9), in the right lobe (n = 3), in the left lobe (n = 4), in segment (S) 2 (n = 1), and in S3 (n = 1). Serum levels of alkaline phosphatase and γ-glutamyltranspeptidase increased in 13 patients. Biloma requiring drainage developed in 2 patients; jaundice developed in 4 patients; and metallic stents were placed in 3 patients. Complications after additional TACE sessions, including biloma (n = 3) and/or jaundice (n = 5), occurred in 7 patients and were treated by additional intervention, including metallic stent placement in 2 patients. After initial TACE of A1 and/or A4, 8 patients (44.4%), including 5 with uncontrollable jaundice or cholangitis, died at 37.9 ± 34.9 months after TACE, and 10 (55.6%) have survived for 38.4 ± 37.9 months. Selective TACE of A1 and/or A4 carries a risk of main bile duct stricture at the hepatic hilum. Biloma and jaundice are serious complications associated with bile duct strictures.

Entities:  

Mesh:

Year:  2010        PMID: 20058008     DOI: 10.1007/s00270-009-9781-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  15 in total

Review 1.  Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yuichi Yoshie; Yoshiko Nakashima; Hiroshi Ikeno; Nobuaki Orito; Miki Yoshida; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

Review 2.  Focal intrahepatic strictures: a review of diagnosis and management.

Authors:  David Yeo; Marcos Vinicius Perini; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

3.  Chemoembolization with drug-eluting beads complicated by intrahepatic biloma.

Authors:  Michael Naumann; Richard Bonsall; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

4.  Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.

Authors:  Nikhil Bhagat; Diane K Reyes; Mingde Lin; Ihab Kamel; Timothy M Pawlik; Constantine Frangakis; J F Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2012-06-22       Impact factor: 2.740

Review 5.  Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-12       Impact factor: 2.740

6.  Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?

Authors:  Jeong Il Yu; Hee Chul Park; Do Hoon Lim; Seung Woon Paik
Journal:  Cancer Res Treat       Date:  2015-07-17       Impact factor: 4.679

7.  Chemoembolization of a hepatocellular carcinoma supplied by a caudate artery forming a common trunk with the supraduodenal artery: A case report.

Authors:  Taishi Amano; Kensaku Mori; Syunsuke Kikuchi; Masafumi Sakai; Sodai Hoshiai; Midori Enokido; Ken Koyama; Manabu Minami
Journal:  Radiol Case Rep       Date:  2020-05-01

8.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06

9.  The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.

Authors:  Jianfei Tu; Zhongzhi Jia; Xihui Ying; Dengke Zhang; Shaoqin Li; Feng Tian; Guomin Jiang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

10.  The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Houyun Xu; Xiping Yu; Jibo Hu
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.